SGX Market Updates By SGX My Gateway

SGX Market Information

SGX My Gateway Market Updates

S-REIT Fund Flows & Performances in 1Q23

27 March 2023

For the first 12 weeks of 2023 the iEdge S-REIT Index generated a 3% total return, with the FTSE EPRA/NAREIT Global REITs Index declining 4%. Within the S-REIT Sector, Industrial S-REITs averaged the highest median total returns over the past 12 weeks at 4%, while Office REITs booked the highest median decline in total return at -8%. The trio of REITs that booked the highest net institutional inflows proportionate to respective current market value over the period are CapitaLand China Trust, Keppel DC REIT and Paragon REIT.

Retailers Bought S$334mil Of Singapore Stocks as STI trades below 3200

SGX My Gateway

20 March 2023

The past 6 sessions (10 March to 17 March) have seen the STI trade below 3,200. The 6 trading sessions saw the Singapore stock market book S$133mil net outflow of institutional fund and S$334mil net inflow of retail fund. Singapore stocks that booked the highest net retail inflows over the six sessions included DBS, UOB, OCBC, Yangzijiang, City Developments, Keppel Corp, Jardine C&C, Suntec REIT, Venture Corp and Jardine Matheson, while Wilmar, Sembcorp and Genting Singapore booked the most net institutional inflow.

Technology Sector Led Global Stocks in January 2023

SGX My Gateway

30 January 2023

Global stocks have been led by the Technology Sector and SEMI Industry over the past 4 weeks, after these segments led declines in 2022. Over the past 4 weeks, Venture Corp, UMS & Frencken have ranked as Singapore’s most traded Technology stocks with the trio averaging 14% gains, while booking S$48 million of net fund inflows. ISDN, which reported 70% of its FY21 revenue to China, led the price performances of the most actively traded SGX-listed tech stocks.

S-REITs In Focus as Earnings Season Begins

SGX My Gateway

20 January 2023

Within the S-REIT Sector, the hospitality segment booked the highest net fund inflows and highest average total returns over the past 13 sessions, followed by the 2 pure-play data centre REITs. This follows the stapled hospitality trusts averaging flat total returns in 2022, while also drawing net fund inflows. Debt-to-asset ratios of S-REITs have anecdotally held some level of investor influence. Key areas of interest for the REIT Sector in 2023 include the impact of energy costs, higher interest rates, occupancy rates, rental reversions, acquisitions, and fundraising.

The Straits Times Index (STI) Led Asia Pacific & Developed Stock Benchmarks in 2022

SGX My Gateway

09 January 2023

The Straits Times Index (STI) generated a 4.1% price gain in 2022, with dividend distributions boosting the total return to 8.4%. This was the strongest stock benchmark performance for year 2022 across the Asia Pacific and Developed Indices, with the FTSE Asia Pacific Index and FTSE Developed Indices declining 16.7% and 18.3% in total return respectively.

The Straits Times Index (STI) on Track to Rank As Most Defensive Global Benchmark in 2022

SGX My Gateway

19 December 2022

The STI outperformance to the FTSE Developed Index was consistent throughout the year, in part due to the Technology Sector weighing the global stock market from the outset. The STI’s technology exposure is limited to Venture Corporation (SGX:V03). The STI’s 7% USD total return for 2022 through to 16 Dec, compared to 18% and 17% declines in USD total return for the FTSE Developed Index and FTSE Emerging Index.

20 SGX Listed Stocks with Most Institutional Fund Inflow In 2022-To-Date Averaged 35% Return

SGX My Gateway

12 December 2022

Of the 20 stocks’ S$3.6bil net institutional buying in 2022 to date, more than S$750mil was contributed since 30 Sep, led by Sembcorp Marine, Genting Singapore and SingTel. These 20 stocks included other non-STI stocks such as Sheng Siong Group and The Hour Glass, with 5 of the non-STI stocks also with market capitalisation below S$1 billion – Riverstone, Hong Fok, Chip Eng Seng, Samudera Shipping and Jiutian Chemical.

SGX Listed China-focused Stocks Gained 5% in November on Key Policy Moves

SGX My Gateway

09 December 2022

Singapore Exchange (SGX) lists close to 100 stocks which derive at least 50% of their revenue from China. The top 10 most traded stocks within this segment, averaged 5.0% total returns in November, reversing October’s 6.8% decline. Amongst the top 3 gainers in the list, Yangzijiang Shipbuilding reported record high total orderbook value as of Nov 13, CapitaLand China Trust saw marked recovery in its retail portfolio in Q3 2022, while Yangzijiang Financial remained on track in its portfolio diversification strategy.

Singapore Most Traded Stocks Average 7% Total Return in November, on S$700M of Net Institutional Fund Inflow

SGX My Gateway

01 December 2022

The Straits Times index (STI) booked a 7% total return in November. The Consumer Cyclical Sector led the most traded stocks over the month with Genting Singapore, Jardine C&C, NIO Inc, The Hour Glass, Parkson Retail Asia and mm2 Asia averaging 15% total returns. Jardine Cycle & Carriage traded 25x its usual trading turnover with S$119 million of net institutional fund inflow with the stock added to the MSCI Singapore Free Index on 30 Nov. SingTel has booked the most net institutional fund inflow over the past 11 months.

SGX Sectors & Stocks That Led the Past Month's Net Fund Inflows

SGX My Gateway

22 November 2022

Among these 100 stocks, the 10 stocks that saw the most net institutional fund inflows proportionate to their current market capitalisation, included 4 Technology stocks – Frencken, UMS, iFAST and Venture Corp, in addition to Sembcorp Marine, CDL Hospitality Trusts, UOB, Acesian Partners, Genting Singapore, and Yangzijiang Shipbuilding.

These articles are provided by SGX My Gateway.

SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.

SGX Stock / REIT Search

STI Index & Stocks Earnings Calendar

TOP 10 SEARCHES
DBS Share Price, OCBC Share Price, SingTel Share Price, UOB Share Price, Keppel Share Price, Seatrium Share Price, SIA Share Price, ST Engineering Share Price, SGX Share Price, SATS Share Price.

NEW STOCKS ON SGX
Lum Chang Creations (SGX:LCC)
China Medical System (SGX:8A8)
NTT DC REIT (SGX:NTDU)
Info-Tech Systems (SGX:ITS)
Vins Holdings (SGX:VIN)

Trust Bank Referral Code